EUROASPIRE IV: A European Society of Cardiology survey on the lifestyle, risk factor and therapeutic management of coronary patients from 24 European countries

Effectiveness of a preventive cardiology programme for high CVD risk persistent smokers: the EUROACTION PLUS varenicline trial

(2014) Catriona Jennings et al.   EUROPEAN HEART JOURNAL

Systematic Review: Glucose Control and Cardiovascular Disease in Type 2 Diabetes

(2013) Tanika N. Kelly   ANNALS OF INTERNAL MEDICINE

2013 ESH/ESC Guidelines for the management of arterial hypertension

(2013)   EUROPEAN HEART JOURNAL

ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD

(2013)   EUROPEAN HEART JOURNAL

Prevalence of a Healthy Lifestyle Among Individuals With Cardiovascular Disease in High-, Middle- and Low-Income Countries

(2013) Koon Teo et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Cost-effectiveness of optimizing prevention in patients with coronary heart disease: the EUROASPIRE III health economics project

(2012) Delphine De Smedt et al.   EUROPEAN HEART JOURNAL

European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)

(2012) et al.   EUROPEAN HEART JOURNAL

Secondary prevention and risk factor target achievement in a global, high-risk population with established coronary heart disease: baseline results from the STABILITY study

(2012) Ola Vedin et al.   European Journal of Preventive Cardiology

Use and effects of cardiac rehabilitation in patients with coronary heart disease: results from the EUROASPIRE III survey

(2012) Kornelia Kotseva et al.   European Journal of Preventive Cardiology

Use of secondary prevention drugs for cardiovascular disease in the community in high-income, middle-income, and low-income countries (the PURE Study): a prospective epidemiological survey

(2011) Salim Yusuf et al.   LANCET

Association of Diet, Exercise, and Smoking Modification With Risk of Early Cardiovascular Events After Acute Coronary Syndromes

(2010) Clara K. Chow et al.   CIRCULATION

Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials

(2010)   LANCET

Intensive glucose control and macrovascular outcomes in type 2 diabetes

(2009) F. M. Turnbull et al.   DIABETOLOGIA

EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries

(2009) Kornelia Kotseva et al.   EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION

Cardiovascular prevention guidelines in daily practice: a comparison of EUROASPIRE I, II, and III surveys in eight European countries

(2009) Kornelia Kotseva et al.   LANCET

Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery disease

(2008) P. Michael Ho et al.   AMERICAN HEART JOURNAL

Smoking Cessation Interventions for Hospitalized Smokers

(2008) Nancy A. Rigotti et al.   ARCHIVES OF INTERNAL MEDICINE

Global Secondary Prevention Strategies to Limit Event Recurrence After Myocardial Infarction

(2008) Pantaleo Giannuzzi   ARCHIVES OF INTERNAL MEDICINE

Modifiable risk factors control and its relationship with 1 year outcomes after coronary artery bypass surgery: insights from the REACH registry

(2008) R. H. Mehta et al.   EUROPEAN HEART JOURNAL

Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster-randomised controlled trial

(2008) DA Wood et al.   LANCET